Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M7,447Revenue (TTM) $M2,242Net Margin (%)10.1Altman Z-Score7.1
Enterprise Value $M8,078EPS (TTM) $1.3Operating Margin %15.5Piotroski F-Score5
P/E(ttm)33.4Beneish M-Score-2.9Pre-tax Margin (%)14.0Higher ROA y-yN
Price/Book4.410-y EBITDA Growth Rate %25.6Quick Ratio--Cash flow > EarningsY
Price/Sales2.85-y EBITDA Growth Rate %16.9Current Ratio--Lower Leverage y-yN
Price/Free Cash Flow18.9y-y EBITDA Growth Rate %-15.5ROA % (ttm)7.6Higher Current Ratio y-yY
Dividend Yield %0.7PEG2.0ROE % (ttm)12.3Less Shares Outstanding y-yN
Payout Ratio %23.0Shares Outstanding M171ROIC % (ttm)12.0Gross Margin Increase y-yY

Gurus Latest Trades with RDY

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
RDYKen Fisher 2016-03-31 Add0.02%$41.22 - $48.86
($44.64)
$ 43.65-2%Add 6.00%4,775,345
RDYKen Fisher 2015-12-31 Reduce-0.06%$43.55 - $67.79
($54.62)
$ 43.65-20%Reduce -9.20%4,504,956
RDYKen Fisher 2015-09-30 Reduce-0.03%$55.59 - $67.73
($62.11)
$ 43.65-30%Reduce -4.55%4,961,550
RDYKen Fisher 2015-06-30 Reduce$51.8 - $60.54
($55.23)
$ 43.65-21%Reduce -0.34%5,198,254
RDYKen Fisher 2015-03-31 Add0.12%$47.73 - $57.1
($53.03)
$ 43.65-18%Add 25.58%5,216,225
RDYKen Fisher 2014-06-30 Add0.13%$38.67 - $46.08
($42.03)
$ 43.654%Add 62.43%3,773,114
RDYKen Fisher 2014-03-31 Add0.08%$39.5 - $47.4
($43.29)
$ 43.651%Add 56.30%2,322,863
RDYKen Fisher 2013-06-30 Add0.04%$32.98 - $38.7
($36.5)
$ 43.6520%Add 48.42%1,283,605
RDYKen Fisher 2013-03-31 Add0.02%$32.03 - $36.57
($34.21)
$ 43.6528%Add 31.46%864,830
RDYKen Fisher 2012-09-30 Buy 0.05%$28.94 - $32.58
($30.12)
$ 43.6545%New holding604,555
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

RDY is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


RDY: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Quarterly/Annual Reports about RDY:

    News about RDY:

    Articles On GuruFocus.com
    Growing Generic Drug Market a Good Opportuity for 2 India Firms May 30 2016 
    Ken Fisher Sells Shares of PMC Sierra, Alphabet During 4th Quarter Jan 15 2016 
    Emerging Market Stocks To Watch Out For Feb 17 2015 
    Should You Buy Actavis? Mar 18 2014 
    Dr. Reddy’s Laboratories: Should Continue to Gain Market Share in Lucrative Markets May 25 2012 
    5 Mid-Cap Healthcare Dividend Stocks with Perfect Earnings Growth Dec 05 2011 
    Abbott Laboratories and the “India Cure” for the Ailing Pharmaceutical Industry May 26 2010 

    More From Other Websites
    ETF’s with exposure to Dr. Reddy’s Laboratories Ltd. : July 29, 2016 Jul 29 2016
    Dr. Reddy's (RDY) Q1 Earnings and Revenues Decline Y/Y Jul 27 2016
    Dr. Reddy's downgraded by Jefferies and HSBC Securities Jul 27 2016
    Dr. Reddy's Tumbles On 1Q Earnings, Venezuela Losses Jul 26 2016
    Dr. Reddy’s Q1 FY17 Financial Results Jul 26 2016
    Dr. Reddy’s Q1 FY17 Financial Results Jul 26 2016
    Dr. Reddy’s Laboratories Ltd. :RDY-US: Earnings Analysis: 2016 By the Numbers : July 26, 2016 Jul 26 2016
    Dr. Reddy’s Q1 FY17 Financial Results Jul 26 2016
    Dr Reddy's Labs Q1 profit slumps 75 percent, misses estimates Jul 26 2016
    Dr Reddy's Labs Q1 profit slumps 75 percent, misses estimates Jul 26 2016
    Will India Benefit from the Brexit Vote? Jul 18 2016
    Dr. Reddy's Laboratories Announces the Launch of Omeprazole and Sodium bicarbonate Capsules in the... Jul 18 2016
    Dr. Reddy's Laboratories Announces the Launch of Omeprazole and Sodium bicarbonate Capsules in the... Jul 18 2016
    Looking For Generic Drug Stocks? Pick Up These Winners Jul 13 2016
    Dr. Reddy's to Release Q1 FY17 Results on July 26, 2016 Earnings Call Slated for July 26, 6.30 PM... Jul 12 2016
    Dr. Reddy's to Release Q1 FY17 Results on July 26, 2016 Earnings Call Slated for July 26, 6.30 PM... Jul 12 2016
    Interview With Value Activist Sandon Capital Jul 11 2016
    Promius Pharma Launches New Corporate Brand Identity Jul 08 2016
    DR REDDYS LABORATORIES LTD Financials Jun 29 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)